COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer
COVID-19
COVID 19 Pandemic: Effect on Management of Patients With Breast Cancer; Single Center Study
1 other identifier
observational
87
1 country
1
Brief Summary
The objective was to find out the impact of COVID-19 on stage of breast cancer at presentation and its effects on overall onco-surgical management. The investigator carried out this research to see the presenting stage of breast cancer in the participants in this pandemic and correlate its effect on stage of breast cancer and upstaging of disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2021
CompletedFirst Submitted
Initial submission to the registry
June 13, 2021
CompletedFirst Posted
Study publicly available on registry
June 18, 2021
CompletedAugust 11, 2021
June 1, 2021
1.1 years
June 13, 2021
August 4, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Duration of delay in presentation to hospital
It was time counted from the day when the participant first felt breast symptom on self assessment or during diagnostic workup and than presented for the first time to hospital for diagnostic or treatment workup purpose
18 months
Duration of delay in definitive treatment
It was counted from the day of first presentation to hospital till the day of initiation of definitive treatment (chemo/surgery)
18 months
Cancer upstaging
It was assessed by reassessing the patient by comparison of disease stage on first time diagnostic workup results and than reassessing the stage of cancer during consecutive visits to hospital , and the effect of delay in treatment and presentation on cancer upstaging of participants related to covid 19 pandemic is evaluated .
18 months
Study Arms (1)
Breast cancer
Interventions
MRM , modified radical mastectomy : removing breast and axilla toilet mastectomy : palliative removal of tumor load BCS ,Breast conservative surgery
Eligibility Criteria
Patient's data of all operated cases for suspicious lump breast (abnormal findings on ultrasound and mammogram, BIRAD III or above and abnormal FNAC results;C3 or above) from January1,2020 to 31 January 2021was retrieved. Out of these only those patients were included in whom the diagnosis of breast cancer was confirmed on histo-pathological examination. Patients who had already had their surgery pre covid (December 2019), were excluded. Data were collected on standard pre-designed questionnaire and from paper documents retrieved from patient records. All patients who were admitted and underwent pre anesthesia assessment underwent COVID testing according to the protocol.
You may qualify if:
- diagnosis of breast cancer confirmed on histo-pathological examination
You may not qualify if:
- Patients who had already had their surgery pre covid (December 2019)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bahria University Medical and Dental College Karachi
Karachi, Sindh, 74800, Pakistan
Related Publications (4)
Gulzar F, Akhtar MS, Sadiq R, Bashir S, Jamil S, Baig SM. Identifying the reasons for delayed presentation of Pakistani breast cancer patients at a tertiary care hospital. Cancer Manag Res. 2019 Jan 29;11:1087-1096. doi: 10.2147/CMAR.S180388. eCollection 2019.
PMID: 30774437BACKGROUNDKhan MA, Shafique S, Khan MT, Shahzad MF, Iqbal S. Presentation delay in breast cancer patients, identifying the barriers in North Pakistan. Asian Pac J Cancer Prev. 2015;16(1):377-80. doi: 10.7314/apjcp.2015.16.1.377.
PMID: 25640384BACKGROUNDVuagnat P, Frelaut M, Ramtohul T, Basse C, Diakite S, Noret A, Bellesoeur A, Servois V, Hequet D, Laas E, Kirova Y, Cabel L, Pierga JY; Institut Curie Breast Cancer and COVID Group; Bozec L, Paoletti X, Cottu P, Bidard FC. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area. Breast Cancer Res. 2020 May 28;22(1):55. doi: 10.1186/s13058-020-01293-8.
PMID: 32460829BACKGROUNDElghazawy H, Bakkach J, Zaghloul MS, Abusanad A, Hussein MM, Alorabi M, Eldin NB, Helal T, Zaghloul TM, Venkatesulu BP, Elghazaly H, Al-Sukhun S. Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic. Future Oncol. 2020 Nov;16(31):2551-2567. doi: 10.2217/fon-2020-0574. Epub 2020 Jul 27.
PMID: 32715776RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Waseem Ahmad Khan, MBBS, FCPS
PNS Shifa Hospital Karachi , HOD department of Surgery
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Target Duration
- 18 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Resident Surgery at PNS Shifa Hospital Karachi
Study Record Dates
First Submitted
June 13, 2021
First Posted
June 18, 2021
Study Start
January 1, 2020
Primary Completion
January 31, 2021
Study Completion
January 31, 2021
Last Updated
August 11, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
impact of present covid 19 pandemic on presentation of breast cancer stage and disease upstaging status if patients are covid positive